Joanne E. Kavanagh, Andrew P. Hearn, David J. Jackson Breathe 2021 17: 210144; DOI: 10.1183/20734735.0144-2021 Abstract There are now several monoclonal antibody (mAb) therapies (“biologics”) available to treat severe asthma. Omalizumab is an anti-IgE mAb and is licensed in severe…
Ariangela J Kozik, Fernando Holguin, Leopoldo N Segal, Talal A Chatila, Anne E Dixon, James E Gern, Catherine Lozupone, Nicholas Lukacs, Carey Lumeng, Philip L Molyneaux, Nichole Reisdorph, Ivan Vujkovic-Cvijin, Alkis Togias, Yvonne J Huang Am J Respir Cell Mol Biol. 2022 Aug;67(2):155-163. Abstract…
Bender B, Oppenheimer J, George M, Brown R, Patel A, Hill T, Boe A, Herrera EM, Dotiwala Z, Casciano J, Bernstein JA. Assessment of real-world escalation to biologics in US…
Oppenheimer J, Hoyte FCL, Phipatanakul W, Silver J, Howarth P, Lugogo NL. Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions. Ann Allergy Asthma…
Phenotype-directed mepolizumab therapy reduced the number of asthma exacerbations among children and adolescents with exacerbation-prone eosinophilic asthma who live in disadvantaged urban neighborhoods, researchers reported in The Lancet. “[I]n urban children…
Kerry L Hancock, 1 Sinthia Bosnic-Anticevich, 2 , 3 , 4 John D Blakey, 5 , 6 Mark Hew, 7 , 8 Li Ping Chung, 9 Biljana Cvetkovski, 3 Scott Claxton, 10 Peter Del Fante, 11 Eve Denton, 7 , 8 Joe Doan, 12 Kanchanamala Ranasinghe, 13 , 14 Lucy Morgan, 15 , 16 , 17 Anita Sharma, 18 Peter K Smith, 19 Deb Stewart, 20 Philip J…
The Journal of Allergy and Clinical Immunology: In Practice Volume 10, Issue 6, June 2022, Pages 1545-1553.e2 MustafaAbdoMDaFraukePedersenPhDabAnneMarieKirstenMDbVeraVeithPhDaHeikeBillerMDaFrederikTrinkmannMDcdErikavon MutiusMDeMatthiasKoppMDfgGesineHansenMDhKlaus F.RabeMD, PhDaThomasBahmerMDai∗HenrikWatzMDb∗ALLIANCE study group Background Little is known about the relationship between…
Summary This webcast will address recent advances in asthma treatment which allow for greater individualization of therapy, particularly for patients with difficult-to-treat and severe asthma. Available therapies are highly effective…
Eur Respir J. 2022 Jun; 59(6): 2101733.Published online 2022 Jun 30. doi: 10.1183/13993003.01733-2021 Stacey N. Reinke,1,2,30Shama Naz,1,30Romanas Chaleckis,1,3Hector Gallart-Ayala,1Johan Kolmert,1,4Nazanin Z. Kermani,5Angelica Tiotiu,5,6David I. Broadhurst,2Anders Lundqvist,7Henric Olsson,8Marika Ström,9,10Åsa M. Wheelock,9,10Cristina Gómez,1,4Magnus Ericsson,11Ana R.…
Research – Open Access Wenqiao Wang, Jiangtao Lin, Xin Zhou, Changzheng Wang, Mao Huang et al. BMC Pulmonary Medicine volume 22, Article number: 261 (2022) Abstract Purpose While asthma comorbidities are associated with higher health care utilisation, lower quality…